Results 131 to 140 of about 124,553,511 (357)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Improved K-Means Algorithm for Nearby Target Localization

IEEE Access
In a multi-source localization system, direction of arrival (DOA) estimation of angles always suffers from errors due to noise interference, sensor position inaccuracies, and other factors.
Zongwen Yuan, Xingdi Wang, Fuyang Chen, Xicheng Ma   +3 more
doaj   +1 more source

Calibration in Array Processing

, 2009
High-resolution direction-or-arrival estimation has been an active area of research since late 1970's. The methods find a wide range of applications, including passive listening arrays, radar and sonar, and spatial (or space-time) characterization of ...
Lundgren, Astrid,, Viberg, Mats,, Lanne, Maria,   +2 more
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

A new direction-of-arrival estimation method using automotive radar sensor arrays [PDF]

, 2017
Seunghoon Cho, Heemang Song, Kyung-Jin You, Hyun‐Chool Shin   +3 more
openalex   +1 more source

Non-identifiability of the two state Markovian Arrival process [PDF]

In this paper we consider the problem of identifiability of the two-state Markovian Arrival process (MAP2). In particular, we show that the MAP2 is not identifiable and conditions are given under which two different sets of parameters, induce identical ...
Michael P. Wiper, Rosa E. Lillo, Pepa Ramirez   +2 more
core  

Precise and faster GNSS signal direction of arrival estimation

, 2013
This paper proposes a precise and fast direction of arrival estimation method using Global Navigation Satellite System (GNSS) carrier phase measurements.
Gill, E. (author), Sun, R., O'Keefe, K., Sun, R. (author), Guo, J., O'Keefe, K. (author), Gill, E., Guo, J. (author)   +7 more
core   +1 more source

Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig, Nadav Amir, Maya Schiller, Roni Loebenstein, Johnatan Nissan, Marina Boxer, Shany Guly Gofrit, Gal Goshen, Sándor Beniczky, Nicola Maggio   +9 more
wiley   +1 more source

MEASUREMENTS OF ARRIVAL TIME DISTRIBUTIONS OF EAS MUONS WITH THE FACILITIES OF THE KASCADE CENTRAL DETECTOR

, 2007
The central detector of the KASCADE experiment is equipped with a trigger and timing facility, which enables measurements of the arrival time distributions of muons hitting the central detector.
M. Foller, Measurements Of Arrival, U. Raidt   +2 more
core  

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source